A detailed history of Td Waterhouse Canada Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 254,020 shares of BMY stock, worth $14.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
254,020
Previous 117,143 116.85%
Holding current value
$14.6 Million
Previous $4.84 Billion 177.39%
% of portfolio
0.11%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $5.43 Million - $7.08 Million
136,877 Added 116.85%
254,020 $13.4 Billion
Q2 2024

Nov 12, 2024

SELL
$40.25 - $52.99 $6.23 Million - $8.2 Million
-154,738 Reduced 56.91%
117,143 $4.84 Billion
Q2 2024

Aug 02, 2024

BUY
$40.25 - $52.99 $9,619 - $12,664
239 Added 0.09%
271,881 $18.9 Billion
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $709,528 - $804,467
-14,788 Reduced 5.16%
271,642 $15 Billion
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $4.63 Million - $5.52 Million
-95,438 Reduced 24.99%
286,430 $16.2 Billion
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $1.21 Million - $1.35 Million
-20,890 Reduced 5.19%
381,868 $23.1 Billion
Q2 2023

Nov 13, 2023

BUY
$63.71 - $70.74 $13.6 Million - $15.1 Million
213,282 Added 112.56%
402,758 $27.1 Billion
Q1 2023

Nov 13, 2023

SELL
$65.71 - $74.53 $372,772 - $422,808
-5,673 Reduced 2.91%
189,476 $14.3 Billion
Q4 2022

Nov 13, 2023

BUY
$68.48 - $81.09 $59,372 - $70,305
867 Added 0.45%
195,149 $15.4 Billion
Q3 2022

Nov 13, 2023

BUY
$0.13 - $76.84 $4,046 - $2.39 Million
31,125 Added 19.08%
194,282 $14.9 Billion
Q2 2022

Nov 13, 2023

SELL
$72.62 - $79.98 $268,113 - $295,286
-3,692 Reduced 2.21%
163,157 $13.5 Billion
Q1 2022

Nov 13, 2023

BUY
$61.48 - $73.72 $138,145 - $165,648
2,247 Added 1.37%
166,849 $13.1 Billion
Q4 2021

Nov 13, 2023

BUY
$53.63 - $62.52 $8.83 Million - $10.3 Million
164,602 New
164,602 $10.9 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.